| Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 YJ Crow, DS Chase, J Lowenstein Schmidt, M Szynkiewicz, GMA Forte, ... American journal of medical genetics Part A 167 (2), 296-312, 2015 | 639 | 2015 |
| Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome P Gissen, CA Johnson, NV Morgan, JM Stapelbroek, T Forshew, ... Nature genetics 36 (4), 400-404, 2004 | 375 | 2004 |
| Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2 DE Neilson, MD Adams, CMD Orr, DK Schelling, RM Eiben, DS Kerr, ... The American Journal of Human Genetics 84 (1), 44-51, 2009 | 371 | 2009 |
| A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency BK Burton, M Balwani, F Feillet, I Barić, TA Burrow, C Camarena Grande, ... New England Journal of Medicine 373 (11), 1010-1020, 2015 | 299 | 2015 |
| Guidelines for management of glycogen storage disease type I–European Study on Glycogen Storage Disease Type I (ESGSD I) J Rake, G Visser, P Labrune, JV Leonard, K Ullrich, PG Smit European journal of pediatrics 161, S112-S119, 2002 | 272 | 2002 |
| Agenesis of the corpus callosum: clinical and genetic study in 63 young patients MF Bedeschi, MC Bonaglia, R Grasso, A Pellegri, RR Garghentino, ... Pediatric neurology 34 (3), 186-193, 2006 | 232 | 2006 |
| Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization AR Cullinane, A Straatman-Iwanowska, A Zaucker, Y Wakabayashi, ... Nature genetics 42 (4), 303-312, 2010 | 202 | 2010 |
| Genotype–phenotype correlations and clinical diagnostic criteria in Wolf‐Hirschhorn syndrome M Zollino, C Di Stefano, G Zampino, P Mastroiacovo, TJ Wright, G Sorge, ... American journal of medical genetics 94 (3), 254-261, 2000 | 202 | 2000 |
| GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790, 2011 | 186 | 2011 |
| Null leukemia inhibitory factor receptor (LIFR) mutations in Stüve-Wiedemann/Schwartz-Jampel type 2 syndrome N Dagoneau, D Scheffer, C Huber, LI Al-Gazali, M Di Rocco, A Godard, ... The American Journal of Human Genetics 74 (2), 298-305, 2004 | 180 | 2004 |
| Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome C Le Goff, C Mahaut, A Abhyankar, W Le Goff, V Serre, A Afenjar, ... Nature genetics 44 (1), 85-88, 2012 | 167 | 2012 |
| Revised recommendations for the management of Gaucher disease in children P Kaplan, H Baris, L De Meirleir, M Di Rocco, A El-Beshlawy, M Huemer, ... European journal of pediatrics 172, 447-458, 2013 | 158 | 2013 |
| Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations E Rossi, F Piccini, M Zollino, G Neri, D Caselli, R Tenconi, C Castellan, ... Journal of medical genetics 38 (6), 417-420, 2001 | 154 | 2001 |
| Clinical features of lysosomal acid lipase deficiency BK Burton, PB Deegan, GM Enns, O Guardamagna, S Horslen, ... Journal of pediatric gastroenterology and nutrition 61 (6), 619-625, 2015 | 151 | 2015 |
| Clinical and molecular genetic features of ARC syndrome P Gissen, L Tee, CA Johnson, E Genin, A Caliebe, D Chitayat, ... Human genetics 120, 396-409, 2006 | 149 | 2006 |
| The medical management of fibrodysplasia ossificans progressiva: current treatment considerations FS Kaplan, M Al Mukaddam, G Baujat, M Brown, A Cali, TJ Cho, C Crowe, ... Proc Intl Clin Council FOP 1, 1-111, 2019 | 147 | 2019 |
| Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease M Biegstraaten, TM Cox, N Belmatoug, MG Berger, T Collin-Histed, ... Blood Cells, Molecules, and Diseases 68, 203-208, 2018 | 143 | 2018 |
| Mutations in OSTM1 (Grey Lethal) Define a Particularly Severe Form of Autosomal Recessive Osteopetrosis With Neural Involvement A Pangrazio, PL Poliani, A Megarbane, G Lefranc, E Lanino, M Di Rocco, ... Journal of Bone and Mineral Research 21 (7), 1098-1105, 2006 | 141 | 2006 |
| Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease B Tappino, R Biancheri, M Mort, S Regis, F Corsolini, A Rossi, ... Human mutation 31 (12), E1894-E1914, 2010 | 139 | 2010 |
| In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome V Carmignac, J Thevenon, L Adès, B Callewaert, S Julia, ... The American Journal of Human Genetics 91 (5), 950-957, 2012 | 136 | 2012 |
